Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOP versus PmitCEBO for good-risk aggressive non-Hodgkin lymphoma
ISRCTN23628366Phase 3Completed
- Sponsor
- British National Lymphoma Investigation
- Start
- Dec 1998
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of cyclophosphamide, doxorubicin, vincristine, prednisolone, mitoxantrone and 2 more in non-Hodgkin lymphoma (NHL) (2 arms), sponsored by British National Lymphoma Investigation. Started Dec 1998; status: completed.
02
Drugs
cyclophosphamidedoxorubicinvincristineprednisolonemitoxantrone
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on ISRCTN23628366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN23628366.